EP 0514970 A1 19921125 - Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers.
Title (en)
Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers.
Title (de)
Pharmazeutische Zusammensetzung für die topische Anwendung zur Behandlung und Reepithelisierung von chronischen, phlebostatischen Ulzern.
Title (fr)
Composition pharmaceutique pour l'utilisation topique pour le traitement et la régénération de l'épithélium d'un ulcer chronique phlébostatique.
Publication
Application
Priority
IT MI911439 A 19910524
Abstract (en)
The association of collagen and heparan sulfate as the active principle in a composition for topical use accelerates the reepithelization of chronic phlebostatic ulcers.
IPC 1-7
IPC 8 full level
A61K 31/715 (2006.01); A61K 38/39 (2006.01); A61P 17/00 (2006.01); A61K 38/17 (2006.01); C07K 14/78 (2006.01); C08B 37/10 (2006.01)
CPC (source: EP KR)
A61K 31/727 (2013.01 - KR); A61K 38/39 (2013.01 - EP); A61P 17/00 (2018.01 - EP)
C-Set (source: EP)
Citation (search report)
- [X] US 4808570 A 19890228 - MICHAELI DOV [US]
- [Y] GB 1205609 A 19700916 - ROUVEIX JACQUES LOUIS MATHIEU [FR]
- [YD] CLINICAL TRIALS JOURNAL vol. 27, no. 1, 1990, pages 1 - 11; L. BOCCI ET AL.: 'Treatment of chronic venous failure secondary to deep venous thrombosis'
- [Y] FASEB JOURNAL vol. 2, 1988, page A344; J. BOLLU ET AL.: 'Effects of Heparin, Heparan Sulfate and Dermatan Sulfate on Fibrinolysis by Tissue Plasminogen Activator'
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL PT SE
DOCDB simple family (publication)
EP 0514970 A1 19921125; CA 2069027 A1 19921125; IT 1249060 B 19950211; IT MI911439 A0 19910524; IT MI911439 A1 19921124; JP H05208915 A 19930820; KR 920021154 A 19921218
DOCDB simple family (application)
EP 92201340 A 19920512; CA 2069027 A 19920520; IT MI911439 A 19910524; JP 15423192 A 19920522; KR 920008816 A 19920525